Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CTO Realty Growth A Pref | CTO-A | Jan 29, 2025 | 22.65 | -0.22 |
CTRL Group | MCTR | Jan 29, 2025 | 5.37 | 0.00 |
CTS | CTS | Jan 29, 2025 | 51.08 | -0.47 |
CubeSmart | CUBE | Jan 29, 2025 | 41.49 | -1.17 |
Cue Biopharma | CUE | Jan 29, 2025 | 1.34 | 0.00 |
Cullen Frost Bankers B Pref | CFR-B | Jan 29, 2025 | 18.41 | -0.75 |
Cullen/Frost Bankers | CFR | Jan 29, 2025 | 138.80 | -1.03 |
Cullinan Therapeutics | CGEM | Jan 29, 2025 | 11.25 | +7.66 |
Culp | CULP | Jan 29, 2025 | 5.40 | +4.65 |
Cumberland Pharmaceuticals | CPIX | Jan 29, 2025 | 2.24 | -5.08 |
Cummins | CMI | Jan 29, 2025 | 354.02 | +1.07 |
Cumulus Media A | CMLS | Jan 29, 2025 | 0.91 | +1.12 |
Curbline Properties | CURB | Jan 29, 2025 | 24.58 | -2.65 |
Curevac N.V. | CVAC | Jan 29, 2025 | 3.87 | -3.49 |
CuriosityStream | CURI | Jan 29, 2025 | 2.14 | -1.38 |
Curis | CRIS | Jan 29, 2025 | 3.22 | +2.88 |
CURRENC Group | CURR | Jan 29, 2025 | 1.71 | +3.64 |
Curtiss-Wright | CW | Jan 29, 2025 | 338.43 | +0.12 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Jan 29, 2025 | 45.10 | +0.89 |
Cushman & Wakefield | CWK | Jan 29, 2025 | 13.60 | -0.80 |
Custom Truck One Source | CTOS | Jan 29, 2025 | 5.19 | +2.17 |
Customers Bancorp | CUBI | Jan 29, 2025 | 57.21 | +0.33 |
Customers Bancorp E Pref | CUBI-E | Jan 29, 2025 | 25.71 | -0.35 |
Customers Bancorp F Pref | CUBI-F | Jan 29, 2025 | 25.51 | -0.40 |
Cutera | CUTR | Jan 29, 2025 | 0.41 | -3.68 |
CVB Financial | CVBF | Jan 29, 2025 | 20.79 | -0.72 |
CVD Equipment | CVV | Jan 29, 2025 | 3.48 | +1.46 |
CVR Energy | CVI | Jan 29, 2025 | 19.67 | +1.18 |
Cvr Partners LP Unit | UAN | Jan 29, 2025 | 82.38 | +0.19 |
CVRx | CVRX | Jan 29, 2025 | 16.85 | -2.71 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.